共 50 条
- [24] Phase 2, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Patients with Myeloid/Lymphoid Neoplasms with Fibroblast Growth Factor Receptor 1 (FGFR1) Rearrangement CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S350 - S351
- [25] Global Developmental Gene Programing Involves a Nuclear Form of Fibroblast Growth Factor Receptor-1 (FGFR1) PLOS ONE, 2015, 10 (04):
- [27] Incidental detection of myeloid/lymphoid neoplasms with fibroblast growth factor receptor 1 rearrangement on fluorodeoxyglucose positron emission tomography EJHAEM, 2023, 4 (04): : 1182 - 1183
- [28] Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1 HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (05): : 696 - 698